Effects of Aromatherapy on Patients Undergoing Chemotherapy for Breast Cancer

Not Applicable

Not yet recruiting

• Conditions: Sleep Quality; Anxiety

• Registration Number: NCT06338527
• Lead Sponsor: Weifang Medical University

Brief Summary

The objective of this study was to investigate the effects of aromatherapy on sleep quality and anxiety in patients undergoing chemotherapy for breast cancer.

Detailed Description

Not available

Study Timeline

• Status Verified: 2024-03
• Study First Submitted: 2024-03-23
• Study Start: 2024-03-26
• Study First Submitted QC: 2024-03-28
• Last Update Submitted: 2024-03-28
• Study First Posted: 2024-03-29
• Last Update Posted: 2024-03-29
• Primary Completion: 2024-06-01
• Study Completion: 2024-06-15

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

1. patients diagnosed with breast cancer and receiving chemotherapy; 2) suffering from sleep disorders or PSQI score greater than 5; 3) not using medications such as antidepressants and hypnotics that may affect the observation results; 4) age older than 18 years and volunteered to participate in this study.

Exclusion Criteria

1. Asthma or severe respiratory disease; 2) Allergy to lavender; 3) Cognitive or communication disorders; 4) Breast cancer combined with severe organ dysfunction.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Sleep quality	The sleep quality of the patients was assessed at 8 a.m. for one week.	The Pittsburgh Sleep Quality Index (PSQI) was used to assess the sleeping quality of the patients. The total score of PSQI ranged from 0-21, with higher scores indicating poor sleep quality.
Anxiety	The anxiety level of the patients was assessed at 8 a.m. for one week.	Beck Anxiety Inventory (BAI) was used to assess the anxiety level of the patients. The scale consists of 21 entries with a total score ranging from 0 to 63, with higher total scores being associated with more severe levels of anxiety.

Trial Locations

Locations (1)

Weifang People's Hospital; 🇨🇳 Weifang, Shangdong, China